Methotrexate as effective as biologics in relieving depression and anxiety among psoriasis patients

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-08-10 04:00 GMT   |   Update On 2023-08-10 07:23 GMT

An ORIGINAL ARTICLE published in the Indian Journal of Dermatology entitled "The effects of methotrexate and biologics on the symptoms of depression and anxiety in patients with psoriasis" by Ugurer et al. mentioned that methotrexate is as effective as biologics in reducing the symptoms of depression and anxiety.

The team said psoriasis patients are often accompanied by psychiatric comorbidities like anxiety/depression, stress, lack of self-esteem, embarrassment, social isolation, and negative effects on life quality. In this study, we compared the effects of methotrexate and biologics on psychiatric comorbidities and examined their relationship with systemic inflammation parameters.

The team enrolled 60 psoriasis patients treated with biologics or methotrexate. At the baseline and the 24th week of the treatment, the patients filled Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Dermatology Life Quality Index (DLQI); inflammation was assessed with serum C-reactive protein (CRP) and tumour necrosis factor-alpha (TNF-α) levels.

Researchers reported that reduced BAI and BDI scores in the 24th week were significant in both groups. In comparison, the decrease in BAI and BDI scores had significant differences. The reduction in DLQI scores of those receiving biologics was superior to those taking methotrexate.

Advertisement

Researchers found no significant correlation between the change in serum inflammation parameters and the decrease in the BDI/BAI scores.

They concluded that psoriasis patients experience reduced anxiety and depression symptoms with biologics and methotrexate.

We noted insignificant differences between the two groups.

They also said Biologics improve life quality better when compared to methotrexate. Systemic inflammation parameters do not reflect the changes in these symptoms in psoriasis patients.

Further reading:

https://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=3;spage=237;epage=244;aulast=Ugurer;type=3

Tags:    
Article Source : Indian Journal of Dermatology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News